Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gozdzik

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Transplantation Proceedings|April 14, 2019
Mesenchymal Stem Cells as a Salvage Treatment for Severe Refractory Graft-vs-Host Disease in Children After Bone Marrow TransplantationA Krasowska-Kwiecien, J Gozdzik, D Jarocha, et al.
Bone Marrow Transplantation|May 22, 2012
Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcomaK Drabko, A Raciborska, K Bilska, et al.
Bone Marrow Transplantation|October 14, 2014
Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patientsJ Gozdzik, K Rewucka, A Krasowska-Kwiecien, et al.
Bone Marrow Transplantation|April 20, 2004
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapyJ Czyz, R Szydlo, W Knopinska-Posluszny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patientsJ Czyz, R Dziadziuszko, W Knopinska-Postuszuy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 24, 2015
Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide studyJ Styczynski, K Czyzewski, M Wysocki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2011
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patientsU Thiel, A Wawer, P Wolf, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Transplantation Proceedings|April 14, 2019
Mesenchymal Stem Cells as a Salvage Treatment for Severe Refractory Graft-vs-Host Disease in Children After Bone Marrow TransplantationA Krasowska-Kwiecien, J Gozdzik, D Jarocha, et al.
Bone Marrow Transplantation|May 22, 2012
Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcomaK Drabko, A Raciborska, K Bilska, et al.
Bone Marrow Transplantation|October 14, 2014
Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patientsJ Gozdzik, K Rewucka, A Krasowska-Kwiecien, et al.
Bone Marrow Transplantation|April 20, 2004
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapyJ Czyz, R Szydlo, W Knopinska-Posluszny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patientsJ Czyz, R Dziadziuszko, W Knopinska-Postuszuy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 24, 2015
Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide studyJ Styczynski, K Czyzewski, M Wysocki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2011
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patientsU Thiel, A Wawer, P Wolf, et al.
Pageof 2